Ledger.Open graph →
SEC Form D · Amendment · filed January 30, 2015

Genomind, Inc

Offering
$6.8M
Sold
$5.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
King of Prussia, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Joseph E. Anton · Boston, MADirectorTheresa E. Sexton · Nashville, TNDirectorGloria E. Nuss · Norfolk, VAExecJohn E. Chadwick · Nashville, TNDirectorStephen E. Haller · Norfolk, VAExecBeth E. Dozoretz · Norfolk, VAExec · DirectorThomas E. Hess · King of Prussia, PAExecMichael I. Koffler · King of Prussia, PAExec · PromoterRonald I. Dozoretz · Norfolk, VAExec · Director · PromoterPCM Capital Select Managers Fund LLC · Kansas City, MODirectorPhalanx Capital GP, LLC · Chicago, ILExec · DirectorRail-Splitter Capital Management, LLC · Chicago, ILDirectorHoward S. Silverman · OMAHA, NEExec · Director · PromoterRobert A. Dean · OMAHA, NEExec · DirectorDouglas L. Dethy · New York, NYExec · DirectorDouglas B. Dunn · Houston, TXExec · Director · PromoterPCM Capital Managed Equity Fund I LLC · Kansas City, MOExec · PromoterAugusto Alvarez · Santa Fe, O5ExecDavid Riker · New York, NYDirectorJack Weiss · New York, NYExec · PromoterJonathan Budd · DEL MAR, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗